My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing
Compugen Ltd (CGEN)
NASDAQ:CGEN

Compugen Stock Analysis & Ratings

Compugen Stock Analysis Overview

Smart Score
4
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The Compugen stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart

CGEN

CGEN Stock Stats

Previous Close$4.39
Open$4.43
Bid0 x 0
Ask0 x 0
Today’s Range$4.16 - $4.45
52-Week Range$4.16 - $15.16
Volume861.18K
Average Volume1.02M
Market Cap$349.10M
Beta2.33
P/E Ratio-11.0
EPS-0.54
Earnings DateFeb 24, 2022

Company Description

Compugen Ltd

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.
Sector
Healthcare
Industry
Biotechnology
CEO
Anat Cohen-Dayag
Employees
68
ISIN
IL0010852080
Address
26 Harokmim Street, Holon, 5885849, IL

Financials


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

CGEN FAQ

What was Compugen’s price range in the past 12 months?
Compugen lowest stock price was $4.16 and its highest was $15.16 in the past 12 months.
    What is Compugen’s market cap?
    Compugen’s market cap is $349.10M.
      What is Compugen’s price target?
      The average price target for Compugen is $17.00. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $18.00 ,the lowest forecast is $16.00. The average price target represents 308.65% Increase from the current price of $4.16.
        What do analysts say about Compugen?
        Compugen’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
          When is Compugen’s upcoming earnings report date?
          Compugen’s upcoming earnings report date is Feb 24, 2022 which is in 82 days.
            How were Compugen’s earnings last quarter?
            Compugen released its earnings results on Nov 12, 2021. The company reported -$0.07 earnings per share for the quarter, beating the consensus estimate of -$0.125 by $0.055.
              Is Compugen overvalued?
              According to Wall Street analysts Compugen’s price is currently Undervalued.
                Does Compugen pay dividends?
                Compugen does not currently pay dividends.
                What is Compugen’s EPS estimate?
                Compugen’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Compugen have?
                Compugen has 83,920,000 shares outstanding.
                  What happened to Compugen’s price movement after its last earnings report?
                  Compugen reported an EPS of -$0.07 in its last earnings report, beating expectations of -$0.125. Following the earnings report the stock price went down -23.883%.
                    Which hedge fund is a major shareholder of Compugen?
                    Among the largest hedge funds holding Compugen’s share is ARK Investment Management LLC. It holds Compugen’s shares valued at 59M.

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis